The global CRISPR and CAS Gene Market Growth Accelerated by Gene Editing Advancements
The
CRISPR and CAS gene editing technology offers precise, powerful and affordable
genome editing capabilities by allowing researchers to easily alter DNA
sequences and modify gene function. This breakthrough technology is being
applied in diverse areas like treating and preventing the development of
diseases, developing improved crops and livestock and industrial applications
like biofuel production.
The
global CRISPR and CAS Gene Market is estimated to be valued at US$ 1.54 Bn in
2023 and is expected to exhibit a CAGR
of 7.0% over the forecast period 2023 to 2030, as highlighted in a new
report published by Coherent Market Insights.
Market key trends:
Advancements
in CRISPR-Cas Technology has been one of the key trends observed in the CRISPR
and CAS Gene Market. Researchers are continuously exploring ways to improve the
current CRISPR-Cas system and make it more efficient and precise. Efforts are
being made to minimize off-target effects, whereby the DNA-editing enzyme can
mistakenly cut DNA sequences that were not intended. New CAS nucleases and gene
delivery methods are being developed to enhance the safety and specificity of
genome editing. The employment of orthogonal Cas systems from different
bacterial strains provides an opportunity to multiplex and finely tune gene
drives with reduced risk of off-target mutations. Such advancements are
expected to widen the scope of CRISPR applications and further drive the growth
of the overall market during the forecast period.
Segment Analysis
The Global
CRISPR And CAS Gene Market Size is dominated by the product sub-segment
which accounted for around 55% share of the overall market in 2023. This is
because CRISPR and CAS Gene are primarily being applied for developing
therapeutic applications and products. The service sub-segment is also growing
at a fast pace due to increasing demand for design and development of
customized genome editing solutions from biotech and pharmaceutical companies.
Key Takeaways
The
global CRISPR and CAS Gene market is expected to witness high growth over the
forecast period from 2023 to 2030.
Regional analysis: North America dominated the global market in 2023 with
around 45% market share owing to heavy investments in genomics and
biotechnology research by government and private entities in the US and Canada.
Asia Pacific is expected to be the fastest growing region during the forecast
period due to rising government funding to develop novel therapeutics using
CRISPR technology in countries like China and India.
Key players: Key players operating in the CRISPR and CAS Gene market are
VeriChip Corporation, Biohax International AB, Dangerous Things LLC, Three
Square Market, Kaspersky Lab, McAfee Corp., Symantec Corporation, ARM Holdings
plc, NXP Semiconductors N.V., Texas Instruments Inc., STMicroelectronics N.V.,
BioTeq Limited, Chip In S.A., Tyco International Ltd., Xerox Corporation.
VeriChip Corporation dominates the market due to its diverse product portfolio
for human implantable radio frequency identification microchips.
Get More Insights On This Topic: https://www.newsstatix.com/crispr-and-cas-gene-market-size-share-analysis-2023-2030/
Comments
Post a Comment